Avian Influenza A(H5N5)- United States of America

Countries / areas
United States of America
First notice
2025-12-05
Latest notice
2025-12-05
Notices
1

Official summary (original text)

On 15 November 2025, WHO was notified of the 71st confirmed human case with influenza A(H5) since early 2024 in the United States of America— the first human case reported in the United States of America since February 2025. On 20 November, U.S. Centers for Disease Control and Prevention (CDC) laboratory sequencing verified the virus as influenza A(H5N5), representing the first globally reported human case caused by an influenza A(H5N5) virus. The investigation by health authorities in the United States of America is ongoing. Contact tracing identified no further cases amongst contacts, and there is currently no evidence of human-to-human transmission.

Due to the constantly evolving nature of influenza viruses, WHO continues to stress the importance of global surveillance to detect and monitor virological (including genomics), epidemiological and clinical changes associated with emerging or circulating influenza viruses that may affect human health and timely virus sharing for risk assessment. Based on available information, the WHO currently assesses the overall public health risk posed by A(H5) viruses as low. However, for individuals with occupational risk of exposure, the risk of infection is considered low to moderate.

WHO risk assessment (original text)

Human infections with avian influenza A(H5) viruses are considered unusual, as A(H5) viruses remain primarily avian influenza viruses. However, in rare cases, individuals exposed to infected animals or contaminated environments can become infected with A(H5) viruses. Influenza A(H5N5) viruses are detected in birds, including wild birds and domestic poultry, and sometimes in non-human mammals. When avian influenza viruses circulate in poultry populations, there is an inherent risk of human infection through exposure to infected birds or contaminated environments. As such, sporadic human cases are expected. The case had underlying conditions and subsequently died. The investigation by health authorities in the United States of America is ongoing and included contact tracing which identified no further cases amongst contacts, and there is currently no evidence of human-to-human transmission.

This is the 71st confirmed human case of A(H5) in the United States of America since early 2024, and the first since February 2025. To date, no human-to-human transmission has been identified in any of the A(H5) cases reported in the United States of America. From a global perspective, while a few events with limited human-to-human transmission of zoonotic influenza A(H5) have been described between 1997 and 2007, sustained human-to-human transmission has not been detected to date.

Based on available information, the WHO currently assesses the overall public health risk posed by A(H5) viruses as low. However, for individuals with occupational risk of exposure, the risk of infection is considered low to moderate.

The risk assessment will be updated as needed, based on any new epidemiological or virological information related to this event.

Read the WHO notice

Notice history

  1. · 2025-DON590

    Avian Influenza A(H5N5)- United States of America

    Official summary (original text)

    On 15 November 2025, WHO was notified of the 71st confirmed human case with influenza A(H5) since early 2024 in the United States of America— the first human case reported in the United States of America since February 2025. On 20 November, U.S. Centers for Disease Control and Prevention (CDC) laboratory sequencing verified the virus as influenza A(H5N5), representing the first globally reported human case caused by an influenza A(H5N5) virus. The investigation by health authorities in the United States of America is ongoing. Contact tracing identified no further cases amongst contacts, and there is currently no evidence of human-to-human transmission.

    Due to the constantly evolving nature of influenza viruses, WHO continues to stress the importance of global surveillance to detect and monitor virological (including genomics), epidemiological and clinical changes associated with emerging or circulating influenza viruses that may affect human health and timely virus sharing for risk assessment. Based on available information, the WHO currently assesses the overall public health risk posed by A(H5) viruses as low. However, for individuals with occupational risk of exposure, the risk of infection is considered low to moderate.

Avian & other zoonotic influenza

Influenza viruses that normally circulate in birds or other animals (e.g. H5N1, H7N9, H9N2) occasionally infect humans. Sustained human-to-human spread has not been seen, but these viruses are closely monitored for pandemic potential.

View all